A comprehensive appropriateness of prescribing questionnaire was validated by nominal consensus group.

J Clin Epidemiol

Centre for Evaluation of Medicines, St. Joseph's Healthcare, McMaster University, 105 Main Street East, P1, Hamilton, Ontario, Canada L8N 1G6.

Published: October 2007

Objective: To develop and validate a comprehensive Appropriateness of Prescribing Evaluation Questionnaire (APEQ) suitable for human and computer use.

Study Design And Setting: This study was part of an ongoing research program examining the effectiveness and cost-effectiveness of computerized prescribing decision support for providers, patients, and drug policy. A nominal group consensus process involved physicians, both primary care physicians and specialists, pharmacists, drug plan managers, patients, patient advocates, and pharmaceutical industry. Structured case scenarios of musculoskeletal problems were used to evaluate APEQ's validity and responsiveness.

Results: Seventeen panelists evaluated 72 patient scenarios in two rounds. Their ratings of appropriateness, assessed by ANOVA, showed significant agreement with the experts' scores in the two rounds, which evaluated appropriateness and responsiveness, respectively. Interrater and intrarater agreement was moderate to good.

Conclusion: This formal assessment suggests that APEQ has reasonable validity, reliability, and responsiveness. Such tools could be very useful in e-prescribing and e-claims reimbursement environments and should be further explored.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2007.01.010DOI Listing

Publication Analysis

Top Keywords

comprehensive appropriateness
8
appropriateness prescribing
8
prescribing questionnaire
4
questionnaire validated
4
validated nominal
4
nominal consensus
4
consensus group
4
group objective
4
objective develop
4
develop validate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!